Skip to main content

. 1990 Oct 6;301(6755):818. doi: 10.1136/bmj.301.6755.818-b

Nephrotic syndrome associated with sulphasalazine.

V M Barbour ¹, P F Williams ¹

PMCID: PMC1663947 PMID: 1977483

818

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Das K. M., Dubin R. Clinical pharmacokinetics of sulphasalazine. Clin Pharmacokinet. 1976 Nov-Dec;1(6):406–425. doi: 10.2165/00003088-197601060-00002. [DOI] [PubMed] [Google Scholar]
Klotz U. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin Pharmacokinet. 1985 Jul-Aug;10(4):285–302. doi: 10.2165/00003088-198510040-00001. [DOI] [PubMed] [Google Scholar]
Novis B. H., Korzets Z., Chen P., Bernheim J. Nephrotic syndrome after treatment with 5-aminosalicylic acid. Br Med J (Clin Res Ed) 1988 May 21;296(6634):1442–1442. doi: 10.1136/bmj.296.6634.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES